-
Cervical Squamous Cell Carcinoma (TCGA, PanCancer Atlas) data
- Description
This dataset contains summary data visualizations and clinical data from a broad sampling of 297 cervical squamous cell carcinomas from 297 patients. The data was gathered as part of the PanCancer Atlas initiative, which aims to answer big, overarching questions about cancer by examining the full set of tumors characterized in the robust TCGA dataset. The clinical data includes mutation count, information...
- Subject
-
Carcinoma, Squamous CellDNA Mutational AnalysisUterine Neoplasms
- Access Rights
- Free to All
-
Uterine Carcinosarcoma (TCGA, PanCancer Atlas)
- Description
This dataset contains summary data visualizations and clinical data from a broad sampling of 57 uterine carcinosarcomas from 57 patients. The data was gathered as part of the PanCancer Atlas initiative, which aims to answer big, overarching questions about cancer by examining the full set of tumors characterized in the robust TCGA dataset. The clinical data includes mutation count, information about...
- Subject
-
CarcinosarcomaDNA Mutational AnalysisMixed Tumor, MullerianUterine Neoplasms
- Access Rights
- Free to All
-
Uterine Corpus Endometrial Carcinoma (TCGA, PanCancer Atlas)
- Description
This dataset contains summary data visualizations and clinical data from a broad sampling of 529 uterine corpus endometrial carcinomas. The data was gathered as part of the PanCancer Atlas initiative, which aims to answer big, overarching questions about cancer by examining the full set of tumors characterized in the robust TCGA dataset. The clinical data includes mutation count, information about...
- Subject
-
Carcinoma, EndometrioidCystadenocarcinoma, PapillaryCystadenocarcinoma, SerousDNA Mutational AnalysisEndometrial NeoplasmsUterine Neoplasms
- Access Rights
- Free to All
-
MSK-IMPACT Clinical Sequencing Cohort (MSKCC, Nat Med 2017): Targeted sequencing of 10,000 clinical cases using the MSK-IMPACT assay
- Description
This dataset contains summary data visualizations and clinical data from the targeted sequencing of 10,000 clinical cases using the MSK-IMPACT assay. The clinical data includes mutation count, information about mutated genes, tumor mutational burden calculations, tissue site from which the sample was derived, tumor purity among other relevant data points. The data set also includes copy-number segment...
- Subject
-
AdenocarcinomaAdenocarcinoma of LungAdenocarcinoma, MucinousBreast NeoplasmsCarcinoma, Ductal, BreastCarcinoma, HepatocellularCarcinoma, LobularCarcinoma, Non-Small-Cell LungCarcinoma, Renal CellCarcinoma, Squamous CellCarcinosarcomaCholangiocarcinomaColonic NeoplasmsColorectal NeoplasmsCystadenocarcinoma, SerousDNA Mutational AnalysisGallbladder NeoplasmsGlioblastomaLiposarcomaLung NeoplasmsLymphoma, FollicularMelanomaMesotheliomaNeoplasms, Squamous CellNeurofibromaOligodendrogliomaOsteosarcomaOvarian NeoplasmsPancreatic NeoplasmsProstatic NeoplasmsRectal NeoplasmsSarcomaSarcoma, SynovialSquamous Cell Carcinoma of Head and NeckStomach NeoplasmsThyroid Cancer, PapillaryUrinary Bladder NeoplasmsUterine NeoplasmsUveal Neoplasms
- Access Rights
- Free to All
-
Endometrial Cancer (MSK, 2018): MSK-IMPACT sequencing of 197 advanced-staged endometrial cancer tumor samples with matched normals, from 189 patients treated at MSK.
- Description
This dataset contains summary data visualizations and clinical data from a broad sampling of endometrial tumors. The data was gathered utilizing the MSK-IMPACT targeted sequencing test. The clinical data includes tumor type (based on the opensource OncoTree ontology developed at MSK), mutation count, information about mutated genes, Fraction Genome Altered, First-Line Therapy PFS, IHC Detail, MMR-D...
- Subject
-
Carcinoma, EndometrioidDNA Mutational AnalysisEndometrial NeoplasmsUterine Neoplasms
- Access Rights
- Free to All
-
Uterine Corpus Endometrial Carcinoma (TCGA, Firehose Legacy)
- Description
TCGA Uterine Corpus Endometrial Carcinoma. Source data from GDAC Firehose. Previously known as TCGA Provisional. This dataset contains summary data visualizations and clinical data from a broad sampling of 549 carcinomas from 548 patients. The data was gathered as part of the Broad Institute of MIT and Harvard Firehose initiative, a cancer analysis pipeline. The clinical data includes mutation count,...
- Subject
-
Carcinoma, EndometrioidCystadenocarcinoma, PapillaryCystadenocarcinoma, SerousDNA Mutational AnalysisEndometrial NeoplasmsUterine Neoplasms
- Access Rights
- Free to All
-
Uterine Carcinosarcoma (TCGA, Firehose Legacy)
- Description
TCGA Uterine Carcinosarcoma. Source data from GDAC Firehose. Previously known as TCGA Provisional. This dataset contains summary data visualizations and clinical data from a broad sampling of 57 carcinomas from 57 patients. The data was gathered as part of the Broad Institute of MIT and Harvard Firehose initiative, a cancer analysis pipeline. The clinical data includes mutation count, information...
- Subject
-
CarcinosarcomaDNA Mutational AnalysisUterine Neoplasms
- Access Rights
- Free to All
-
Uterine Sarcoma/Mesenchymal: Targeted Sequencing of 108 Uterine Sarcoma/Mesenchymal tumor/normal pairs from 107 patients
- Description
This dataset contains the summary data visualizations and clinical data from targeted sequencing of 108 Uterine Sarcoma/Mesenchymal tumor normal pairs from 107 patients. Clinical data includes: Cancer Type, Number of Samples Per Patient, Mutation Count, Fraction Genome Altered, Primary/Metastasis Sample Type, Cancer Type - Detailed Code, Current Cancer Stage, Gene Panel, Impact TMB Score, Initial...
- Subject
-
AdenosarcomaLeiomyosarcomaSarcomaSarcoma, Endometrial StromalSmooth Muscle TumorUterine Cervical NeoplasmsUterine Neoplasms
- Access Rights
- Free to All
-
The Angiosarcoma Project - Count Me In (Nature Medicine, 2020)
- Description
Dataset Summary Description: "The Angiosarcoma Project is an ongoing patient-driven initiative. This archived Angiosarcoma Project dataset was analyzed in the linked Nature Medicine 2020 manuscript, and is derived from 48 samples from 36 angiosarcoma patients. Angiosarcoma tumor specimens (FFPE) were subjected to whole-exome sequencing (along with matched germline whole-exome sequencing). In addition...
- Subject
-
AdenocarcinomaBasal Cell CarcinomaBreast NeoplasmsHemangiosarcomaHodgkin DiseaseLeukemia, Lymphocytic, Chronic, B-CellRectal NeoplasmsSkin NeoplasmsThyroid NeoplasmsUterine NeoplasmsVulvar Neoplasms
- Access Rights
- Free to All
-
The Angiosarcoma Project (Provisional): an ongoing patient-driven initiative.
- Description
Dataset Summary Description: "This provisional dataset is currently derived from 83 samples, including tumor specimens (FFPE and cfDNA) from 62 angiosarcoma patients subjected to WES (along with matched germline WES). This study includes genomic data, patient-reported data (pre-pended as PRD), medical record data (MedR), and pathology report data (PATH). As these data were generated in a research...
- Subject
-
Basal Cell CarcinomaBreast NeoplasmsColorectal NeoplasmsHemangiosarcomaHodgkin DiseaseLeukemia, Lymphocytic, Chronic, B-CellProstatic NeoplasmsRectal NeoplasmsSkin NeoplasmsThyroid NeoplasmsUterine NeoplasmsVulvar Neoplasms
- Access Rights
- Free to All